DEPEN TAB 250MG DIN 00511641
Health Canada record
| Active ingredient(s) | PENICILLAMINE 250 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | M01CC01 PENICILLAMINE |
| Original market date | 31-Dec-1981 |
| Current status date | 19-Aug-2003 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PENICILLAMINE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00016055 | CUPRIMINE | BAUSCH HEALTH, CANADA INC. | Capsule | PENICILLAMINE 250 MG | Marketed |
| 00497894 | CUPRIMINE | MERCK CANADA INC | Capsule | PENICILLAMINE 125 MG | Cancelled Post Market |
International API supply for PENICILLAMINE
3 valid EDQM Certificates of Suitability from 3 holders. 11 active FDA Drug Master Files.
Request a quote for DEPEN TAB 250MG